Global Bio CMO Market 2018 Edition – Lonza Group, Boehringer Ingelheim, Samsung Biologics, Wuxi Biologics Profiled

Global Bio CMO Market: Size, Trends & Forecasts (2018 Edition)“, provides analysis of the global bio CMO market, with detailed analysis of market size and growth, penetration rate, and manufacturing process. A brief segment analysis is provided with their actual and forecasted value. In addition, an analysis of the global biologics market by value, by top selling products, etc. is also mentioned in the report.

Growth of the overall global bio CMO market has been forecasted for the years 2018-2022, taking into consideration the previous growth pattern, the growth drivers and the current and future trends.

Lonza Group, Boehringer Ingelheim, Samsung Biologics and Wuxi Biologics are key companies in the global bio CMO market. The company profiling of these companies has been done in the report, which includes business overview, financial overview and respective business strategies of the companies.


Company Coverage

Lonza Group
Boehringer Ingelheim
Samsung Biologics
Wuxi Biologics

Executive Summary

The pharmaceutical industry is a vital component of health care system globally and is mainly comprised of large number of private as well as public organizations that discover, develop, produce, and market drugs for medical use. World’s major pharmaceutical companies are located in the North America, Europe and Japan. On the basis of technological platform, pharmaceutical drugs can be categorized into small molecule or conventional drugs and large molecule or biologic drugs.

Biologics are made through biological processes and are generally injected. Biologics comprises of vaccines, blood or blood components, somatic cells, gene therapy, etc. These are categorized into first-or second generation, depending on development period and cell line. Biosimilars are the biological that are similar, but not identical to the original product.

CMO or Contract Manufacturing Organization is a third party, which the pharmaceutical firms approach for the manufacturing of components of its product or whole of its product. A contract manufacturing organization (CMO) undertakes the production of product(s) under the brand name of another firm Bio CMOs are typically used to provide secondary manufacturing coverage for the branded pharmaceutical industry. On the basis of production technology, bio CMOs can be divided into mammalian cell system and microbial system.

The global bio CMO market has shown upward trends over the past few years and is anticipated to follow the same trend in the coming years as well. The market is expected to rise at a significant growth rate over the forecasted period (2018-2022). Growth drivers, such as increase in pharmaceutical industry, potential biologics blockbusters, introduction of targeted therapins, grater outsourcing demand from global pharmas, etc. would help the market to grow.

Buy this report via Credit Card/Paypal or Wire Transfer:

Contact Us:
Ritesh Tiwari, Director
USA: +1-800-416-3124

Follow us on Social Media:


Ritesh Tiwari is the Founder of Research By Markets. He has more than 7 years experience in the Market Research industry and a total experience spanning 18+ years. His core experience is in Sales and International Recruitments. Ritesh is a big foodie and a huge football fan, supporting Manchester United (EPL) and FC Barcelona (La Liga). He hardly misses watching any matches when these teams are playing. Get in touch with Ritesh via: *Industry Press Release is a part of Research By Markets.